Molecular cancer therapy: Fulvestrant, an estrogen receptor antagonist, increases the expression of tumor suppressor TIMP3 via down regulation of its target gene, 26/March/2014, 5.04 am

Molecular cancer therapy: Fulvestrant, an estrogen receptor antagonist, increases the expression of tumor suppressor TIMP3 via down regulation of its target gene, 26/March/2014, 5.04 am

Molecular cancer therapy: Fulvestrant, an estrogen receptor antagonist, increases the expression of tumor suppressor TIMP3 via down regulation of its target gene, 26/March/2014, 5.04 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Molecular cancer therapy: Fulvestrant, an estrogen receptor antagonist, increases the expression of tumor suppressor TIMP3 via down regulation of its target gene, 26/March/2014, 5.04 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing